Filings & corporate actions
- 5 NovresultsResults · Q2 FY27 · consolidated and standalone-4.1%NSE
- 16 OctshareholdingShareholding · 30 Sept 2026+1.1%NSE
- 6 AugresultsResults · Q1 FY27 · consolidated and standalone-2.7%NSE
- 20 JulshareholdingShareholding · 8 Jul 2026+3.9%NSE
- 16 JulshareholdingShareholding · 30 Jun 2026-4.2%NSE
- 28 MayresultsResults · Q4 FY26 · standalone+4.6%NSE
- 13 MayresultsResults · Q4 FY26 · consolidated and standalone-1.5%NSE
- 16 AprshareholdingShareholding · 31 Mar 2026+2.1%NSE
- 13 MarshareholdingShareholding · 6 Mar 2026+0.7%NSE
- 29 JanresultsResults · Q3 FY26 · consolidated and standalone-0.6%NSE
- 13 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE
Reaction to results · all yearsrose on day 0 in 39 of 79 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 5 Nov 2026 | -4.1% | +0.6% | — | 0.5× |
| Q1 FY27 | 6 Aug 2026 | -2.7% | 0.0% | +15.9% | 0.8× |
| Q4 FY26 | 13 May 2026 | -1.5% | +28.5% | +27.9% | 0.8× |
| Q3 FY26 | 29 Jan 2026 | -0.6% | +29.0% | +13.5% | 0.7× |
| Q2 FY26 | 11 Nov 2025 | -2.6% | -4.6% | -10.2% | 1.0× |
| Q1 FY26 | 13 Aug 2025 | +1.3% | -0.6% | -2.8% | 1.1× |
| Q4 FY25 | 13 May 2025 | +7.5% | +23.6% | +44.2% | 6.6× |
| Q3 FY25 | 24 Jan 2025 | -4.2% | +7.3% | -2.9% | 0.6× |
| Q2 FY25 | 29 Oct 2024 | +5.3% | +13.7% | +10.1% | 1.5× |
| Q1 FY25 | 5 Aug 2024 | -4.7% | -7.4% | +8.4% | 0.6× |
| Q4 FY24 | 7 May 2024 | -5.0% | -10.3% | -21.9% | 0.9× |
| Q3 FY24 | 30 Jan 2024 | -3.2% | +5.0% | -9.2% | 0.2× |
| Q2 FY24 | 4 Nov 2023 | +4.0% | +10.5% | +7.9% | 1.1× |
| Q1 FY24 | 8 Aug 2023 | +1.7% | -0.5% | -0.2% | 3.7× |
| Q4 FY23 | 10 May 2023 | +0.4% | -0.9% | +1.6% | 0.5× |
| Q3 FY23 | 3 Feb 2023 | -1.7% | -1.0% | -6.3% | 1.2× |
| Q2 FY23 | 11 Nov 2022 | +0.6% | +1.5% | +3.1% | 0.4× |
| Q1 FY23 | 26 Jul 2022 | +1.2% | +3.0% | +1.4% | 0.9× |
| Q4 FY22 | 7 May 2022 | -3.0% | +0.7% | -6.8% | 0.5× |
| Q3 FY22 | 1 Feb 2022 | -0.4% | -1.7% | -12.0% | 0.3× |
| Q2 FY22 | 26 Oct 2021 | +3.4% | +5.7% | -3.6% | 0.4× |
| Q1 FY22 | 10 Aug 2021 | -6.6% | -0.4% | -0.4% | 1.4× |
| Q4 FY21 | 5 May 2021 | -3.1% | -1.7% | -4.8% | 0.8× |
| Q3 FY21 | 28 Jan 2021 | -1.4% | +14.8% | +18.0% | 0.5× |
| Q2 FY21 | 28 Oct 2020 | -2.4% | -6.4% | -4.6% | 0.5× |
| Q1 FY21 | 12 Aug 2020 | -6.2% | -1.7% | -9.7% | 1.5× |
| Q4 FY20 | 6 Jun 2020 | -2.3% | -9.6% | +13.8% | 1.2× |
| Q3 FY20 | 14 Feb 2020 | +5.0% | +33.7% | -16.0% | 2.7× |
| Q2 FY20 | 14 Nov 2019 | -3.0% | -2.6% | -13.5% | 5.6× |
| Q1 FY20 | 15 Aug 2019 | +0.8% | +10.5% | +22.5% | 0.7× |
| Q4 FY19 | 25 May 2019 | +1.8% | +1.6% | +1.9% | 1.6× |
| Q3 FY19 | 1 Mar 2019 | +3.0% | +6.2% | +3.7% | 1.2× |
| Q2 FY19 | 22 Nov 2018 | -1.5% | -5.5% | -11.8% | 0.5× |
| Q1 FY19 | 5 Sept 2018 | +4.3% | +17.8% | -6.2% | 0.7× |
| Q4 FY18 | 26 May 2018 | +3.0% | -3.2% | +12.8% | 0.9× |
| Q3 FY18 | 10 Feb 2018 | +2.4% | -1.7% | -9.3% | 0.4× |
| Q2 FY18 | 22 Nov 2017 | +0.8% | -1.4% | -6.5% | 1.0× |
| Q1 FY18 | 1 Sept 2017 | +0.3% | -3.1% | +8.2% | 0.7× |
| Q4 FY17 | 26 May 2017 | +6.2% | +6.2% | -2.0% | 1.9× |
| Q3 FY17 | 2 Feb 2017 | +1.0% | +3.8% | -3.0% | 0.8× |
| Q2 FY17 | 28 Nov 2016 | -0.2% | +2.7% | -8.2% | 0.7× |
| Q1 FY17 | 21 Sept 2016 | +0.4% | +1.2% | +5.5% | 0.5× |
| Q4 FY16 | 30 May 2016 | -0.8% | -2.2% | -6.7% | 0.6× |
| Q3 FY16 | 13 Feb 2016 | +0.5% | -14.3% | +16.9% | 3.8× |
| Q2 FY16 | 10 Nov 2015 | +1.6% | -1.6% | -5.4% | 2.4× |
| Q1 FY16 | 16 Aug 2015 | -3.2% | -14.2% | -10.2% | 1.6× |
| Q4 FY15 | 28 May 2015 | +2.8% | -8.2% | -10.3% | 0.9× |
| Q3 FY15 | 10 Feb 2015 | -3.1% | +4.3% | +4.8% | 1.2× |
| Q2 FY15 | 22 Nov 2014 | -0.2% | -0.4% | +5.6% | 0.3× |
| Q1 FY15 | 21 Aug 2014 | +1.6% | +26.4% | +55.1% | 1.3× |
| Q4 FY14 | 27 May 2014 | +4.0% | +9.7% | +17.8% | 0.7× |
| Q3 FY14 | 5 Feb 2014 | -1.7% | -6.8% | -4.1% | 1.1× |
| Q2 FY14 | 18 Nov 2013 | +8.5% | +4.8% | +6.9% | 2.9× |
| Q1 FY14 | 19 Aug 2013 | +5.6% | +9.7% | +44.2% | 1.2× |
| Q4 FY13 | 20 May 2013 | -2.6% | -9.4% | -11.8% | 0.5× |
| Q3 FY13 | 12 Feb 2013 | +4.9% | -2.2% | -3.2% | 3.0× |
| Q2 FY13 | 16 Nov 2012 | -6.2% | -12.7% | +8.9% | 0.7× |
| Q1 FY13 | 14 Aug 2012 | +9.6% | +29.1% | +48.0% | 8.0× |
| Q4 FY12 | 7 May 2012 | -3.9% | -9.0% | -11.0% | 1.0× |
| Q3 FY12 | 31 Jan 2012 | -0.6% | +3.5% | -7.3% | 2.2× |
| Q2 FY12 | 1 Nov 2011 | +0.3% | -5.0% | -12.6% | 5.4× |
| Q1 FY12 | 18 Aug 2011 | +0.9% | -2.6% | -0.9% | 2.5× |
| Q4 FY11 | 30 May 2011 | -0.9% | +1.6% | -8.9% | 0.7× |
| Q3 FY11 | 31 Jan 2011 | -1.2% | -6.0% | -12.7% | 1.8× |
| Q2 FY11 | 27 Oct 2010 | -1.0% | -6.2% | -10.9% | 1.4× |
| Q1 FY11 | 27 Jul 2010 | -2.3% | -3.1% | -3.5% | 2.3× |
| Q4 FY10 | 30 Apr 2010 | +5.0% | -6.1% | -15.2% | 1.5× |
| Q3 FY10 | 27 Jan 2010 | -5.7% | -3.5% | -13.3% | 1.1× |
| Q2 FY10 | 31 Oct 2009 | -4.5% | -0.2% | +3.4% | 0.8× |
| Q1 FY10 | 28 Jul 2009 | -3.8% | -5.6% | +47.6% | 2.4× |
| Q4 FY09 | 29 Apr 2009 | +0.7% | +17.2% | +73.1% | 0.4× |
| Q3 FY09 | 19 Jan 2009 | +3.2% | -0.7% | -13.2% | 4.3× |
| Q2 FY09 | 31 Oct 2008 | +20.0% | +20.0% | +12.3% | 4.6× |
| Q1 FY09 | 25 Jul 2008 | +1.7% | +9.3% | -2.3% | 2.1× |
| Q4 FY08 | 26 Apr 2008 | -4.4% | -1.7% | -2.9% | 0.6× |
| Q3 FY08 | 28 Jan 2008 | -3.0% | +4.7% | -5.7% | 0.5× |
| Q2 FY08 | 30 Oct 2007 | +4.0% | -0.3% | +6.0% | 3.0× |
| Q1 FY08 | 10 Aug 2007 | +0.5% | -4.4% | -7.7% | 1.2× |
| Q4 FY07 | 26 Apr 2007 | -0.1% | -7.6% | -14.3% | 2.6× |
| Average | +0.3% | +2.1% | +2.6% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +4.0% | -10.0% | -13.9% | +7.8% | -13.6% | — |
| Profit | — | — | — | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions SUVEN settled 40.8% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 42.9%, so recent sessions are running 2.1 points lower than usual. The latest session ranks higher than 49% of the 3,629 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -2.71% | -3.02% | +0.45% | -27.89% | -0.04% | +44.52% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 2.8 | 1.5 | 3.6 | 1.2 |
| YoY chg | +74.5% | +3.6% | +91.0% | +30.4% |
| Net profit (₹ Cr) | (101.9) | (45.6) | (127.6) | (106.9) |
| YoY chg | — | — | — | — |
| Net margin | -3628.8% | -2999.5% | -3578.7% | -8922.3% |
| EPS | -4.55 | -2.02 | -4.84 | -3.77 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 65.47% · public 34.53%- Promoter
- Public and others
- Promoter
- 65.47%
- Public
- 34.53%
- Promoter change
- 0.00 pp
- Filed
- 16 Oct 2026
- FII
- 0.46%
- DII
- 2.17%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 0.08%
- Insurance
- 0.00%
- FPI
- 0.45%
- Retail ≤ ₹2L
- 17.70%
- HNI > ₹2L
- 7.15%
- NRI
- 1.46%
- Bodies corporate
- 4.56%
- Shareholders
- 67,431
+0.07 pp QoQ
0.00 pp QoQ
-0.03 pp QoQ
-0.01 pp QoQ
+0.46 pp QoQ
-0.01 pp QoQ
+0.14 pp QoQ
+1.2% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED (In its Capacity as sole trustee of Jasti Family Trust) | Promoter · Corporate | 64.93% | 18.35Cr |
| TEJAS TRIVEDI | Individual | 1.34% | 37.81L |
| KETAN C SHETH | Individual | 1.21% | 34.08L |
| SUDHARANI JASTI | Promoter · Individual | 0.54% | 15.29L |
| VENKATESWARLU JASTI | Promoter · Individual | 0.00% | 2.2K |
| KALYANI JASTI | Promoter · Individual | 0.00% | 1.0K |
| SIRISHA JASTI | Promoter · Individual | 0.00% | 1.0K |
| MADHAVI JASTI | Promoter · Individual | 0.00% | 1.0K |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2018-19 | 1 | ₹1.50 | ₹1.50 |
| FY2017-18 | 1 | ₹1.50 | ₹1.50 |
| FY2016-17 | 1 | ₹1.00 | ₹1.00 |
| FY2015-16 | 2 | ₹2.60 | ₹2.60 |
| FY2014-15 | 1 | ₹2.50 | ₹2.50 |
| FY2013-14 | 1 | ₹0.30 | ₹0.30 |
| FY2012-13 | 1 | ₹0.30 | ₹0.30 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 14 Feb 2019 | — | ₹1.50 | ₹1.50 |
| 6 Feb 2018 | — | ₹1.50 | ₹1.50 |
| 8 Feb 2017 | — | ₹1.00 | ₹1.00 |
| 14 Mar 2016 | — | ₹2.00 | ₹2.00 |
| 23 Jul 2015 | — | ₹0.60 | ₹0.60 |
| 24 Jul 2014 | — | ₹2.50 | ₹2.50 |
| 1 Aug 2013 | — | ₹0.30 | ₹0.30 |
| 17 Sept 2012 | — | ₹0.30 | ₹0.30 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 10.6 years ago
- Disclosures on record
- 8
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 2 Sept 2020 | VENKATA RAMUDU JASTHIRelative | Buy | 15.0K | ₹7.4L | 49.30 | 50.0K → 65.0K | 0.05%+0.01 pp | 7(2)told 1 Sept 2020 |
| 31 Aug 2020 | VENKATA RAMUDU JASTHIRelative | Buy | 10.0K | ₹5.4L | 53.81 | 40.0K → 50.0K | 0.04%+0.01 pp | 7(2)told 29 Aug 2020 |
| 27 Aug 2020 | VENKATA RAMUDU JASTHIRelative | Buy | 20.0K | ₹10.5L | 52.72 | 20.0K → 40.0K | 0.03%+0.01 pp | 7(2)told 27 Aug 2020 |
| 24 Aug 2020 | VENKATA RAMUDU JASTHIRelative | Buy | 20.0K | ₹10.0L | 50.01 | — → 20.0K | 0.02% | 7(2)told 24 Aug 2020 |
| 31 Mar 2016 | JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITEDPromoter | Buy | 5.50L | ₹10.8Cr | 195.99 | 7.58Cr → 7.64Cr | 60.00%+0.43 pp | 7(2)told 30 Mar 2016 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Bulk & block deals · 11 Jan 2024
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 11 Jan 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 14.29L | 121.82 | ₹17.4Cr |
| 11 Jan 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 14.29L | 121.70 | ₹17.4Cr |
| 13 Sept 2023 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 15.35L | 78.20 | ₹12.0Cr |
| 13 Sept 2023 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 15.35L | 78.12 | ₹12.0Cr |
| 23 Apr 2021 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 6.41L | 109.97 | ₹7.0Cr |
| 23 Apr 2021 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 6.41L | 109.64 | ₹7.0Cr |
| 17 Dec 2020 | Buy · bulk | ALPHA LEON ENTERPRISES LLP | 6.56L | 104.94 | ₹6.9Cr |
| 17 Dec 2020 | Sell · bulk | ALPHA LEON ENTERPRISES LLP | 6.27L | 105.08 | ₹6.6Cr |
| 18 Sept 2020 | Buy · bulk | KATKAR SANJAY | 6.89L | 56.27 | ₹3.9Cr |
| 21 Apr 2020 | Sell · bulk | ALPHA LEON ENTERPRISES LLP | 7.62L | 32.17 | ₹2.5Cr |
| 21 Apr 2020 | Buy · bulk | ALPHA LEON ENTERPRISES LLP | 7.50L | 29.75 | ₹2.2Cr |
| 26 Mar 2020 | Buy · bulk | ALPHA LEON ENTERPRISES LLP | 7.44L | 24.86 | ₹1.9Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
- High-low range > 150% in 12 months · since 8 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 150% in 12 months.
- High-low range > 200% in 1 year · since 1 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 200% in 1 year.
- Zero EPS (4 quarters) · since 6 Dec 2024 — Zero EPS over the last four quarters.
- Loss making · since 23 Jan 2024 — The company reported a loss.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25A | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 2.5 | 2.4 | 1.0 | 2.6 | 1.6 | 1.5 | 1.9 | 0.9 | 2.8 | 1.5 | 3.6 | 1.2 | |
| Other income | 6.1 | 4.3 | 4.0 | 4.0 | 1.6 | 1.2 | 0.6 | 3.8 | 2.8 | 6.8 | 7.5 | 6.7 | |
| Total income | 8.5 | 6.7 | 5.0 | 6.6 | 3.2 | 2.7 | 2.5 | 4.7 | 5.6 | 8.3 | 11.1 | 7.9 | |
| Total expenses | 50.3 | 34.2 | 33.1 | 56.3 | 42.4 | 46.6 | 54.0 | 82.0 | 107.5 | 53.9 | 138.7 | 114.9 | |
| └ Finance costs | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.5 | 0.5 | |
| └ Depreciation | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.3 | 1.4 | 1.3 | 1.3 | 1.6 | 2.2 | 2.3 | |
| Profit before tax | (41.8) | (27.5) | (28.0) | (49.6) | (39.1) | (43.9) | (51.5) | (77.3) | (101.9) | (45.6) | (127.6) | (106.9) | |
| Tax expense | 0.0 | (1.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net profit | (41.8) | (26.5) | (28.0) | (49.6) | (39.1) | (43.9) | (51.5) | (77.3) | (101.9) | (45.6) | (127.6) | (106.9) | |
| EPS | -1.92 | -1.22 | -1.29 | -2.27 | -1.79 | -2.02 | -2.36 | -3.48 | -4.55 | -2.02 | -4.84 | -3.77 | |
| Net margin | -1704.13% | -1112.72% | -2787.25% | -1929.49% | -2429.75% | -2995.56% | -2759.78% | -8410.56% | -3628.79% | -2999.51% | -3578.73% | -8922.25% | |
| PBT margin | -1704.13% | -1154.75% | -2787.25% | -1929.49% | -2429.75% | -2995.56% | -2759.78% | -8410.56% | -3628.79% | -2999.51% | -3578.73% | -8922.25% | |
| Tax rate | — | — | — | — | — | — | — | — | — | — | — | — |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 388.9 | 350.3 | 284.9 | 212.0 | 135.2 | 337.4 | 624.2 | 506.4 | |
| Current assets | 251.6 | 216.0 | 256.7 | 186.6 | 75.5 | 278.2 | 546.7 | 383.3 | |
| └ Cash & equivalents | 37.0 | 18.6 | 14.9 | 7.4 | 15.0 | 9.6 | 8.3 | 24.1 | |
| └ Other bank balances | 147.3 | 105.4 | 149.0 | 85.1 | 22.7 | 1.2 | 329.2 | 308.9 | |
| └ Current investments | 46.3 | 64.4 | 75.9 | 74.0 | 22.3 | 246.7 | 0.0 | 13.7 | |
| └ Trade receivables | 0.8 | 1.0 | 1.3 | 1.5 | 1.3 | 1.1 | 1.5 | 1.5 | |
| └ Inventories | 0.0 | 0.7 | 0.7 | 0.7 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Total equity | 375.3 | 338.4 | 270.0 | 192.7 | 110.0 | 281.3 | 591.4 | 453.6 | |
| └ Attributable to owners | 375.3 | 338.4 | 270.0 | 192.7 | 110.0 | 281.3 | 591.4 | 453.6 | |
| └ Non-controlling interest | 0.0 | — | — | 0.0 | — | 0.0 | — | — | |
| └ Share capital | 21.8 | 21.8 | 21.8 | 21.8 | 21.8 | 22.7 | 26.4 | 28.3 | |
| Borrowings | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Current | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Non-current | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Trade payables | 1.7 | 3.5 | 2.1 | 4.6 | 5.2 | 5.0 | 4.8 | 3.6 | |
| Current liabilities | 11.1 | 9.8 | 13.5 | 17.9 | 23.5 | 54.4 | 30.9 | 39.5 | |
| Total liabilities | 13.6 | 11.8 | 14.9 | 19.3 | 25.2 | 56.1 | 32.8 | 52.8 | |
| Net debt | (230.6) | (188.4) | (239.9) | (166.2) | (60.0) | (257.5) | (337.5) | (346.8) | |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current ratio | 22.61 | 21.98 | 18.99 | 10.40 | 3.21 | 5.11 | 17.69 | 9.70 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | (207.9) | (29.6) | (82.6) | (80.3) | (154.1) | (103.4) | (301.8) | (221.8) | |
| └ Capex | (2.9) | (0.4) | (2.4) | (0.1) | (37.3) | (2.1) | (5.1) | (45.9) | |
| Free cash flow | (210.8) | (30.0) | (85.0) | (80.4) | (191.4) | (105.5) | (306.9) | (267.7) | |
| Investing cash flow | (155.7) | 11.7 | 61.6 | 73.3 | 155.0 | (201.6) | (462.1) | 145.1 | |
| Financing cash flow | 395.5 | (0.5) | (1.1) | (0.5) | (0.8) | 299.5 | 757.2 | 92.6 | |
| └ Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 31.7 | (18.4) | (22.1) | (7.5) | 0.1 | (5.4) | (6.7) | 15.8 |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →SUVEN at a glance
- SUVEN closed at ₹269.4 on 20 Nov 2026, -2.71% on the day, +44.5% over one year, 33.2% below its 52-week high of ₹403.35.
- Delivery was 48.1% of traded quantity on 20 Nov 2026, the 49th percentile of its own 3,629 sessions with a reading (20-session average 40.8%, 1-year average 42.9%).
- Market capitalisation is ₹7,612 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-13.52).
- Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹1 crore (+30.4% year on year), net profit ₹-107 crore; the price moved -4.1% on the first session after.
- Promoters held 65.47% at 30 Sept 2026, unchanged on the previous filing.
- Q3 FY27 results are expected between 24 Jan 2027 and 3 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 5 Oct 2026Healthcare › Healthcare › Healthcare Services › Healthcare Research Analytics & Technology
- from 5 Oct 2026Index industry · Healthcare
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Healthcare Services
- APAPOLLOHOSPApollo Hospitals Enterprise Limited9,200.00+5.29%
- MAMAXHEALTHMax Healthcare Institute Limited1,081.00+3.88%
- PAPARASHLTHPARASHLTH844.65+1.16%
- FOFORTISFortis Healthcare Limited825.00+1.87%
- SYSYNGENESyngene International Limited451.70+3.28%
- ASASTERDMAster DM Quality Care Limited779.30+5.41%
- MAMANIPALHOSManipal Health Enterprises Limited702.20+0.83%
- LALALPATHLABDr. Lal Path Labs Ltd.2,006.00+2.18%
- THTHYROCAREThyrocare Technologies Limited528.45+4.67%
- ININDGNIndegene Limited657.65+1.90%
- MEMEDANTAGlobal Health Limited1,480.20+0.13%
- NHNHNarayana Hrudayalaya Ltd.1,943.70+3.77%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE